Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bestwick

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2015
Systematic review and meta-analysis of salivary protein concentration in Parkinson's diseaseJoseph M Masters, Jonathan Bestwick, Thomas T Warner, et al.
European Journal of Neurology|May 26, 2022
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosisAshok Adams, William Tilden, Jonathan Bestwick, et al.
Movement Disorders Clinical Practice|January 26, 2023
Gender Differences in the Prevalence of Parkinson's DiseaseAlexandra Zirra, Shilpa C Rao, Jonathan Bestwick, et al.
British Journal of Pain|April 14, 2022
A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell diseasePaul Telfer, Jonathan Bestwick, James Elander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderMoneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2019
Evolution and clustering of prodromal parkinsonian features in GBA1 carriersStephen Mullin, Michelle Beavan, Jonathan Bestwick, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2020
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completedKathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cellsFrancesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2020
Parkinson's disease determinants, prediction and gene-environment interactions in the UK BiobankBenjamin Meir Jacobs, Daniel Belete, Jonathan Bestwick, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2015
Systematic review and meta-analysis of salivary protein concentration in Parkinson's diseaseJoseph M Masters, Jonathan Bestwick, Thomas T Warner, et al.
European Journal of Neurology|May 26, 2022
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosisAshok Adams, William Tilden, Jonathan Bestwick, et al.
Movement Disorders Clinical Practice|January 26, 2023
Gender Differences in the Prevalence of Parkinson's DiseaseAlexandra Zirra, Shilpa C Rao, Jonathan Bestwick, et al.
British Journal of Pain|April 14, 2022
A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell diseasePaul Telfer, Jonathan Bestwick, James Elander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderMoneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2019
Evolution and clustering of prodromal parkinsonian features in GBA1 carriersStephen Mullin, Michelle Beavan, Jonathan Bestwick, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2020
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completedKathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cellsFrancesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2020
Parkinson's disease determinants, prediction and gene-environment interactions in the UK BiobankBenjamin Meir Jacobs, Daniel Belete, Jonathan Bestwick, et al.
Pageof 3